PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 36 filers reported holding PROTARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,649 | +58.4% | 23,143 | +126.7% | 0.00% | – |
| Q2 2023 | $24,397 | -83.2% | 10,208 | -78.2% | 0.00% | – |
| Q1 2023 | $145,349 | +231.8% | 46,887 | +186.8% | 0.00% | – |
| Q4 2022 | $43,812 | -91.3% | 16,348 | -90.4% | 0.00% | – |
| Q3 2022 | $505,000 | -29.0% | 170,522 | -29.7% | 0.00% | – |
| Q2 2022 | $711,000 | -65.8% | 242,571 | -40.3% | 0.00% | – |
| Q1 2022 | $2,076,000 | -28.2% | 406,248 | -5.2% | 0.00% | -100.0% |
| Q4 2021 | $2,892,000 | +20.6% | 428,366 | +23.7% | 0.00% | – |
| Q3 2021 | $2,398,000 | -30.3% | 346,431 | -2.0% | 0.00% | -100.0% |
| Q2 2021 | $3,441,000 | -9.5% | 353,321 | +46.3% | 0.00% | 0.0% |
| Q1 2021 | $3,801,000 | – | 241,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
| Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
| Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
| Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
| Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
| Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
| OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |